Signaling pathways of chronic kidney diseases, implications for therapeutics
Q Yuan, B Tang, C Zhang - Signal transduction and targeted therapy, 2022 - nature.com
Chronic kidney disease (CKD) is a chronic renal dysfunction syndrome that is characterized
by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) …
by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) …
[HTML][HTML] Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases
Y Song, J Liu, K Zhao, L Gao, J Zhao - Cell metabolism, 2021 - cell.com
High levels of cholesterol are generally considered to be associated with atherosclerosis. In
the past two decades, however, a number of studies have shown that excess cholesterol …
the past two decades, however, a number of studies have shown that excess cholesterol …
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
A Mitrofanova, S Merscher, A Fornoni - Nature Reviews Nephrology, 2023 - nature.com
Chronic kidney disease (CKD) is a global health problem with rising incidence and
prevalence. Among several pathogenetic mechanisms responsible for disease progression …
prevalence. Among several pathogenetic mechanisms responsible for disease progression …
The glomerular filtration barrier: a structural target for novel kidney therapies
IS Daehn, JS Duffield - Nature Reviews Drug Discovery, 2021 - nature.com
Loss of normal kidney function affects more than 10% of the population and contributes to
morbidity and mortality. Kidney diseases are currently treated with immunosuppressive …
morbidity and mortality. Kidney diseases are currently treated with immunosuppressive …
Mechanisms of podocyte injury and implications for diabetic nephropathy
F Barutta, S Bellini, G Gruden - Clinical Science, 2022 - portlandpress.com
Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies,
including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and …
including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and …
Mitochondrial dysfunction in diabetic kidney disease
JM Forbes, DR Thorburn - Nature Reviews Nephrology, 2018 - nature.com
Globally, diabetes is the leading cause of chronic kidney disease and end-stage renal
disease, which are major risk factors for cardiovascular disease and death. Despite this …
disease, which are major risk factors for cardiovascular disease and death. Despite this …
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
S Agrawal, JJ Zaritsky, A Fornoni… - Nature Reviews …, 2018 - nature.com
Nephrotic syndrome is a highly prevalent disease that is associated with high morbidity
despite notable advances in its treatment. Many of the complications of nephrotic syndrome …
despite notable advances in its treatment. Many of the complications of nephrotic syndrome …
[HTML][HTML] Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism
Y Fu, Y Sun, M Wang, Y Hou, W Huang, D Zhou… - Cell Metabolism, 2020 - cell.com
Lipid accumulation in podocytes is a major determinant of diabetic kidney disease (DKD)
and identification of potential therapeutic targets by mediating podocyte lipid metabolism …
and identification of potential therapeutic targets by mediating podocyte lipid metabolism …
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis
LH Mariani, S Eddy, FM AlAkwaa, PJ McCown… - Kidney international, 2023 - Elsevier
The diagnosis of nephrotic syndrome relies on clinical presentation and descriptive patterns
of injury on kidney biopsies, but not specific to underlying pathobiology. Consequently, there …
of injury on kidney biopsies, but not specific to underlying pathobiology. Consequently, there …
Lipotoxicity in kidney, heart, and skeletal muscle dysfunction
H Nishi, T Higashihara, R Inagi - Nutrients, 2019 - mdpi.com
Dyslipidemia is a common nutritional and metabolic disorder in patients with chronic kidney
disease. Accumulating evidence supports the hypothesis that prolonged metabolic …
disease. Accumulating evidence supports the hypothesis that prolonged metabolic …